We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Continuous Glucose Sensor Aids Diabetics

By HospiMedica staff writers
Posted on 07 Apr 2006
A medical device that continuously monitors glucose will greatly improve the quality of diabetes care and lower the risk of complications such as loss of sight, heart attacks, kidney failure, and amputation. More...
It is an important step toward the development of an artificial pancreas for people suffering from diabetes.

The Juvenile Diabetes Research Foundation (JDRF, New York, NY, USA), a charitable supporter of research on type 1 diabetes, has announced that a new device, the Short Term Sensor (STS) continuous glucose monitoring system, has been approved by the U.S. Food and Drug Administration (FDA). Developed by DexCom Inc., (San Diego, CA, USA), the monitoring system is a patient-insertable short-term sensor that wirelessly transmits blood-glucose readings to a handheld receiver.

The wire-like sensor is inserted via an applicator by the user or clinician just under the skin and held in place by an adhesive to the skin. Once inserted, the user wears the sensor for up to three days when the patient removes and discards it. A new sensor is then used with the same receiver. The STS receiver provides continuous glucose values, one-, three-, and nine-hour glucose trend information, high- and low-glucose alerts, and low-glucose alarm. The patient is able to adjust medication, diet, and exercise according to the glucose levels.

Monitors such as these are the keys to the development of a closed-loop glucose testing and insulin delivery system, or an "artificial pancreas.” Closed loop technology will provide patients with far more information about their daily glucose fluctuations and trends and allow for far-tighter control. Patients who aggressively manage their diabetes typically test their glucose levels up to eight times a day, and provide insulin injections based on that information. The artificial pancreas will test the glucose approximately 1,400 times a day, and make insulin available based on real-time information.

"The development of an artificial pancreas has been one of JDRF's top research goals, and we are cautiously optimistic that these new products will be as successful and beneficial to people with diabetes as we hope,” said Aaron Kowalski, Ph.D., Director of research projects at JDRF.



Related Links:
JDRF
DexCom

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.